Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons

Annals of Neurology

Volumn 48, Issue 1, 2000, Pages 77-87

  Ginsberg, Stephen D ^a,c   Hemby, Scott E ^b,d   Lee, Virginia M Y ^a   Eberwine, James H ^b   Trojanowski, John Q ^a,b  

^a Center for Neurodegenerative Disease Research   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; COMPLEMENTARY DNA; CYTOSKELETON PROTEIN; DOPAMINE RECEPTOR; FOCAL ADHESION KINASE; GLUTAMATE RECEPTOR; MESSENGER RNA; PHOSPHATASE; PHOSPHOTRANSFERASE; UTROPHIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXPRESSED SEQUENCE TAG; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NERVE CELL; NEUROFIBRILLARY TANGLE; NORTHERN BLOTTING; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; DNA, COMPLEMENTARY; FEMALE; HIPPOCAMPUS; HUMANS; IN SITU HYBRIDIZATION; MALE; NEUROFIBRILLARY TANGLES; RNA, ANTISENSE; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0033933738     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.0.CO;2-A     Document Type: Article

References (49)

1. Ginsberg SD, Schmidt ML, Crino PB, et al. Molecular pathology of Alzheimer's disease and related disorders. In: Peters A, Morrison JH, eds. Cerebral cortex, vol 14. Neurodegenerative and age-related changes in structure and function of cerebral cortex. New York: Kluwer Academic/Plenum, 1999:603-653
2. Goedert M, Trojanowski JQ, Lee M-Y. The neurofibrillaty pathology of Alzheimer's disease. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, eds. The molecular and genetic basis of neurological disease. 2nd ed. Boston: Butterworth-Heinemann, 1997:613-627
3. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705
4. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43:815-825
5. Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998;95:7737-7741
6. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998;282:1914-1917
7. Selkoe DJ. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 1997;275:630-631
8. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996;14:1675-1680
9. O'Dell DM, McIntosh TK, Eberwine JH. Single-cell molecular biology: implications for the diagnosis and treatment of neurological disease. Arch Neurol 1999;56:1453-1456
10. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996;274:998-1001
11. Chow N, Cox C, Callahan LM, et al. Expression profiles of multiple genes in single neurons of Alzheimer's disease. Proc Natl Acad Sci USA 1998;95:9620-9625
12. Serafini T. Of neurons and gene chips. Curr Opin Neurobiol 1999;9:641-644
13. Ginsberg SD, Crino PB, Lee VM-Y, et al. Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. Ann Neurol 1997;41:200-209
14. Ginsberg SD, Galvin JE, Chiu T-S, et al. RNA sequestration to pathological lesions of neurodegenerative disorders. Acta Neuropathol (Berl) 1998;96:487-494
15. Hasegawa M, Crowther RA, Jakes R, Goedert M. Alzheimer-like changes in microtubule-associated protein tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation. J Biol Chem 1997;273:33118-33124
16. Kampers T, Friedhoff P, Biernat J, et al. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett 1996;399:344-349
17. Ginsberg SD, Crino PB, Hemby SE, et al. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann Neurol 1999;45:174-181
18. Van Deerlin VMD, Ginsberg SD, Lee VM-Y, Trojanowski JQ. The use of fixed human postmortem brain tissue to study mRNA expression in neurodegenerative diseases: applications of microdissection and mRNA amplification. In: Geschwind D, Gregg J, eds. DNA microarrarys: techniques for neuroscience. Boston: MIT Press, 2000 (in press)
19. Crino PB, Dichter MA, Trojanowski JQ, Eberwine JH. Embryonic markers in tuberous sclerosis: single-cell molecular pathology. Proc Natl Acad Sci USA 1996;93:14152-14157
20. VanGelder R, von Zastrow M, Yool A, et al. Amplified RNA (aRNA) synthesized from limited quantities of heterogeneous cDNA. Proc Nad Acad Sci USA 1990;87:1663-1667
21. Eberwine J, Yeh H, Miyashiro K, et al. Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA 1992;89: 3010-3014
22. Greenberg SG, Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 1990;87: 5827-5831
23. Lee VM-Y, Garden MJ, Schlaepfer WW, Trojanowski JQ. Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats. J Neurosci 1987;7:3474-3488
24. Ginsberg SD, Price DL, Blackstone CD, et al. GluR3 is the major AMPA glutamate receptor of oxytocinergic magnocellular neurons and is localized at synapses. Neuroscience 1995;65: 563-575
25. Callahan LM, Vaules WA, Coleman PD. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J Neuropathol Exp Neurol 1999;58: 275-287
26. Hyman BT, Elvhage TE, Reiter J. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease. Am J Pathol 1994; 144:565-572
27. Harrison PJ, Barton AJ, Najlerahim A, et al. Regional and neuronal reductions of polyadenylated messenger RNA in Alzheimer's disease. Psychol Med 1991;21:855-866
28. Griffin WS, Ling C, White CL III, Morrison-Bogorad M. Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease. Alzheimer Dis Assoc Disord 1990;4:69-78
29. Joyce JN, Kaeger C, Ryoo H, Goldsmith S. Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease. Neurosci Lett 1993;154:171-174
30. Ryoo HL, Joyce JN. Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease. J Comp Neurol 1994;348:94-110
31. Ikonomovic MD, Sheffield R, Armstrong DM. AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal formation of patients with Alzheimer's disease. Hippocampus 1995;5:469-486
32. Ikonomovic MD, Mizukami K, Davies P, et al. The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains. J Neuropathol Exp Neurol 1997;56:1018-1027
33. Burnashev N, Monyer H, Seeburg PH, Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 1992;8:189-198
34. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170
35. Hyman BT, Van Hoesen GW, Damasio AR. Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology 1990;40:1721-1730
36. Sze CI, Troncoso JC, Kawas C, et al. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol 1997;56:933-944
37. Shimohama S, Kamiya S, Taniguchi T, et al. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease. Biochem Biophys Res Commun 1997;236:239-242
38. Heffernan JM, Eastwood SL, Nagy Z, et al. Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia. Exp Neurol 1998;150:235-239
39. Cataldo AM, Barnett JL, Berman SA, et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 1995;14:671-680
40. Cataldo AM, Hamilton DJ, Barnett JL, et al. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 1996;16:186-199
41. Lyford G, Yamagata K, Kaufmann W, et al. Arc, a growth factor and activity regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 1995;14:433-445
42. Steward O, Wallace CS, Lyford GL, Worley PF. Synaptic activation causes the mRNA for the IEG arc to localize selectively near activated postsynaptic sites on dendrites. Neuron 1998;21: 741-751
43. Zhang C, Qiu HE, Krafft GA, Klein WL. Protein kinase C and F-actin are essential for stimulation of neuronal FAK tyrosine phosphorylation by G-proteins and amyloid beta protein. FEBS Lett 1996;386:185-188
44. Berg MM, Krafft GA, Klein WL. Rapid impact of β-amyloid on paxillin in a neural cell line. J Neurosci Res 1997;50:979-989
45. Balijepalli S, Tirumalai PS, Swamy KV, et al. Rat brain thioltransferase: regional distribution, immunological characterization, and localization by fluorescent in situ hybridization. J Neurochem 1999;72:1170-1178
46. Chrestensen CA, Eckman CB, Starke DW, Mieyal JJ. Cloning, expression and characterization of human thioltransferase (glutaredoxin) in E. coli. FEBS Lett 1995;374:25-28
47. Zheng M, Storz G. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 1998;279: 1718-1721
48. Blake DJ, Tinsley JM, Davies KE. Utrophin: a structural and functional comparison to dystrophin. Brain Pathol 1996;6: 37-47
49. Morris GE, Nguyen TM, Nguyen TN, et al. Disruption of the utrophin-actin interaction by monoclonal antibodies and prediction of an actin-binding surface of utrophin. Biochem J 1999;337:119-123